분자유전학실험실 (단국대학교 분자생물학과)

 이성욱 ( 2010-12-10 11:56:19 , Hit : 2472
 Microbe gets toxic response

Researchers question the science behind last week's revelation of arsenic-based life.

Alla Katsnelson

Days after an announcement that a strain of bacteria can apparently use arsenic in place of phosphorous to build its DNA and other biomolecules — an ability unknown in any other organism — some scientists are questioning the finding and taking issue with how it was communicated to non-specialists.

Many readily agree that the bacterium, described last week in Science and dubbed GFAJ-1 (F. Wolfe-Simon et al. Science doi:10.1126/science.1197258; 2010), performs a remarkable feat by surviving high concentrations of arsenic in California's Mono Lake and in the laboratory. But data in the paper, they argue, suggest that it is just as likely that the microbe isn't using the arsenic, but instead is scavenging every possible phosphate molecule while fighting off arsenic toxicity. The claim at a NASA press briefing that the bacterium represents a new chemistry of life is at best premature, they say.

"It's a great story about adaptation, but it's not ET," says Gerald Joyce, a biochemist at the Scripps Research Institute in La Jolla, California.

At the press briefing, Steven Benner, a chemist at the Foundation for Applied Molecular Evolution in Gainesville, Florida, who was invited to the event to offer outside comment, used the analogy of a steel chain with a tinfoil link to illustrate that the arsenate ion said to replace phosphate in the bacterium's DNA forms bonds that are orders of magnitude less stable. Not only would the organism's DNA have to stay together in spite of the weaker bonds, says Benner, but so would all the molecules required to draw arsenate from the environment and build it into the genetic material. Co-authors of the paper, including Paul Davies, an astrobiologist at Arizona State University in Tempe, have countered that the arsenate bonds could be reinforced by specialized molecules, or that arsenic-based life simply has a higher turnover for molecular disintegration and assembly than does conventional life.

The big problem, however, is that the authors have shown that the organism takes up arsenic, but they "haven't unambiguously identified any arsenic-containing organic compounds", says Roger Summons, a biogeochemist at the Massachusetts Institute of Technology in Cambridge. "And it's not difficult to do," he adds, noting that the team could have directly confirmed or disproved the presence of arsenic in the DNA or RNA using targeted mass spectrometry.

Some researchers suggest that the authors' own data hint at an organism that is simply absorbing and isolating arsenate while making use of the trace phosphates in its environment. For one thing, says Joyce, the paper shows that the organisms appear bloated, and contain large, vacuole-like structures — often a sign of sequestered toxic material. The arsenate-grown cells were analysed in their resting phase, which requires less phosphate for survival than does active growth, notes Joyce, and cells grown in high concentrations of arsenate did not seem to contain any RNA — possibly because RNA production had shut down to conserve phosphate. One calculation in the paper showed that the DNA in arsenate-grown cells actually contained 26 times more phosphorus than arsenic.

"I fault the authors for not noticing these things and sorting them out," says Rosemary Redfield, a microbiologist at the University of British Columbia in Vancouver, Canada, whose summary of the paper's problems, posted on her blog on 4 December, has already had more than 30,000 hits. "We shouldn't have to do the thinking for them."

Felisa Wolfe-Simon, a NASA astrobiology research fellow at the US Geological Survey in Menlo Park, California, and the study's lead author, refused to address criticisms. "We are not going to engage in this sort of discussion," she wrote in an e-mail to Nature. "Any discourse will have to be peer-reviewed in the same manner as our paper was, and go through a vetting process so that all discussion is properly moderated."

But Jonathan Eisen, a microbiologist at the University of California, Davis, calls this "ludicrous", after a NASA press release drew media attention with claims of an "astrobiology finding that will impact the search for evidence of extraterrestrial life", a theme that Wolfe-Simon echoed at the briefing. "It is absurd for them to say that they are only going have the discussion in the scientific literature, when they started it," he says.

Ginger Pinholster, a spokeswoman for Science 's publisher, the American Association for the Advancement of Science in Washington DC, noted that the journal regards significant responses to high-visibility articles, as well as efforts to replicate the work, as a "key goal of publication". Pinholster also pointed out that the journal's own press summary of the paper made no mention of the search for extraterrestrial life, nor did Science "organize any additional promotional events".

Published online 7 December 2010 | Nature 468, 741 (2010) | doi:10.1038/468741a

947   Merck’s Hepatitis C Drug Wins F.D.A. Approval  이성욱 2011/05/17 2291
946   Mice Get Human Livers  이성욱 2010/02/24 4445
  Microbe gets toxic response  이성욱 2010/12/10 2472
944   microRNA Discovery Might Help ALS Patients  이성욱 2009/12/14 4788
943   MicroRNAs Prevent Cell Reprogramming  이성욱 2011/10/27 3645
942   microRNA가 췌장암 치료제가 될 수 있을까  이성욱 2015/06/30 1179
941   MicroRNA를 매개하여 C형 간염을 치료하는 인터페론  이성욱 2007/10/25 4725
940   Minimal Genome Created  이성욱 2016/03/26 965
939   miRNA로 암줄기세포를 통제한다  이성욱 2007/12/20 5132
938   miRNA를 이용한 계통발생 분석의 문제점  이성욱 2014/08/01 1730
937   miRNA를 이용한 암살상바이러스의 지향성(tropism) 강화  이성욱 2008/11/01 4733
936   miRNA를 침묵시켜 C형간염을 치료  이성욱 2009/12/07 4706
935   miRNA와 Ago2에 의한 혈구세포의 발달과정 규명  이성욱 2007/08/02 5895
934   miro RNA  정흥수 2003/09/01 3985
933   Missing Molecules Hold Promise of Therapy for Pancreatic Cancer: Lost microRNAs Put Brakes on Tumors  이성욱 2010/12/22 2272
932   MIT 선정 2015년 주목받은 Biomedicine 뉴스  이성욱 2016/02/03 1008
931   Molecular discovery suggests new strategy to fight cancer drug resistance  이성욱 2010/06/25 2386
930   Molecular Mechanism Triggering Parkinson's Disease Identified - miRNA  이성욱 2010/08/02 2475
929   Molecular scalpel hope for Duchenne muscular dystrophyBy James Gallagher  이성욱 2011/07/28 2945
928   More support for RNAi in clinic  이성욱 2010/03/23 2910

[이전 10개] [1]..[11][12][13][14][15][16] 17 [18][19][20]..[64] [다음 10개]

Copyright 1999-2024 Zeroboard / skin by ROBIN